Skip to content

Completed

Stress & Premenstrual Symptoms Study

Psychophysiology, Neurosteroids, and Stress in Premenstrual Dysphoric Disorder

Status
Completed
Registry ID
NCT02777372
Type
Interventional (tests a treatment)
Phase
Phase 4
Conditions
PMDD, Stress, Mood
What is tested
Sertraline (drug)
Sponsor
Johns Hopkins University
Where
United States
Participants
84
Start
2016-04-01
Completion
2021-12-01
Last update
2025-06-12
Results posted
Yes

About the study

This study that aims to evaluate the psychophysiology of premenstrual mood disorders (PMDs) at baseline and after treatment with sertraline. Participants will include women with PMDs and healthy female controls. Participation involves a baseline visit to determine eligibility and three study visits that include questionnaires and stress reactivity assessment via an acoustic startle paradigm. Female participants with PMDs will receive sertraline during the premenstrual phase.

Summary from ClinicalTrials.gov.

See the full record